• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL16介导的FGD5-AS1上调通过靶向miR-195-5p/SLC7A2轴促进骨肉瘤进展。

METTL16-Mediated Upregulation of FGD5-AS1 Promotes Progression of Osteosarcoma through Targeting of miR-195-5p/SLC7A2 Axis.

作者信息

Wu Weiqian, Zheng Wenbiao, Pan Weiwei, Chen Fanghu, Jiang Langqing

机构信息

Department of Orthopedics, Taizhou Municipal Hospital, Taizhou City, Zhejiang Province 318000, China.

Taizhou Municipal Hospital.

出版信息

Crit Rev Eukaryot Gene Expr. 2025;35(5):17-31. doi: 10.1615/CritRevEukaryotGeneExpr.2025058118.

DOI:10.1615/CritRevEukaryotGeneExpr.2025058118
PMID:40530965
Abstract

Dysregulated long noncoding RNAs (lncRNAs) promote the progression of osteosarcoma (OS). This study aimed to investigate the potential of lncRNA FGD5-AS1 in OS. Gene expression was determined using RT-qPCR. Protein expression was detected by western blot. N6-methyladenosine (m6A) modification was confirmed by MeRIP. Cell behaviors were detected using CCK-8, colony formation, and transwell assays. The interaction between miR-195-5p and the FGD5-AS1/SLC7A2 axis was confirmed by luciferase assays. FGD5-AS1 was upregulated in OS, induced by METTL16 via mediating m6A modification. However, FGD5-AS1 knockdown inhibited the proliferation and epithelial-mesenchymal transition (EMT) of OS cells. FGD5-AS1 sponged miR-195-5p to mediate the upregulation of SLC7A2, overexpression of which promoted aggressiveness of OS cells. In summary, METTL16-mediated upregulation of FGD5-AS1 promotes the aggressiveness of OS though targeting of miR-195-5p/SLC7A2 axis.

摘要

长链非编码RNA(lncRNA)失调促进骨肉瘤(OS)进展。本研究旨在探究lncRNA FGD5-AS1在骨肉瘤中的作用。采用RT-qPCR检测基因表达。通过蛋白质印迹法检测蛋白质表达。通过MeRIP法确认N6-甲基腺苷(m6A)修饰。使用CCK-8、集落形成和Transwell实验检测细胞行为。通过荧光素酶实验确认miR-195-5p与FGD5-AS1/SLC7A2轴之间的相互作用。FGD5-AS1在骨肉瘤中上调,由METTL16通过介导m6A修饰诱导产生。然而,敲低FGD5-AS1可抑制骨肉瘤细胞的增殖和上皮-间质转化(EMT)。FGD5-AS1吸附miR-195-5p以介导SLC7A2的上调,SLC7A2的过表达促进骨肉瘤细胞的侵袭性。总之,METTL16介导的FGD5-AS1上调通过靶向miR-195-5p/SLC7A2轴促进骨肉瘤的侵袭性。

相似文献

1
METTL16-Mediated Upregulation of FGD5-AS1 Promotes Progression of Osteosarcoma through Targeting of miR-195-5p/SLC7A2 Axis.METTL16介导的FGD5-AS1上调通过靶向miR-195-5p/SLC7A2轴促进骨肉瘤进展。
Crit Rev Eukaryot Gene Expr. 2025;35(5):17-31. doi: 10.1615/CritRevEukaryotGeneExpr.2025058118.
2
LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma.长链非编码 RNA FGD5-AS1 通过调控 miR-154-5p/WNT5A 轴增强骨肉瘤细胞自噬相关阿霉素耐药性。
Cell Biol Int. 2022 Nov;46(11):1937-1946. doi: 10.1002/cbin.11889. Epub 2022 Aug 30.
3
Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.长链非编码 RNA FGD5-AS1 通过靶向 miR-506-3p/RAB3D 轴增强骨肉瘤细胞的增殖和迁移。
Hum Cell. 2021 Jul;34(4):1255-1265. doi: 10.1007/s13577-021-00536-w. Epub 2021 Apr 23.
4
Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.长链非编码 RNA FGD5-AS1 的沉默通过调节 miR-493-5p/DDX5 轴抑制非小细胞肺癌的进展。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990007. doi: 10.1177/1533033821990007.
5
EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.EBF1 通过作为 ceRNA 调节 miR-124-3p/G3BP2 轴上调 lncRNA FGD5-AS1 促进骨肉瘤进展。
J Orthop Surg Res. 2022 Jun 27;17(1):332. doi: 10.1186/s13018-022-03181-7.
6
Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.长链非编码 RNA HNF1A-AS1 通过调节 miR-32-5p/HMGB1 轴调控骨肉瘤进展。
Cancer Biother Radiopharm. 2021 May;36(4):371-381. doi: 10.1089/cbr.2019.3486. Epub 2020 Jul 20.
7
Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).靶向 lncRNA FGD5-AS1/miR-497-5p/PD-L1 轴抑制结直肠癌(CC)中的恶性表型。
Biomed Res Int. 2022 Jul 6;2022:1133332. doi: 10.1155/2022/1133332. eCollection 2022.
8
FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.FGD5-AS1 通过调控 miR-129-5p/HNRNPK 轴促进胶质母细胞瘤进展,激活 Wnt/β-catenin 信号通路。
Life Sci. 2020 Sep 1;256:117998. doi: 10.1016/j.lfs.2020.117998. Epub 2020 Jun 22.
9
Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.长链非编码 RNA PGM5-AS1 通过损害 miR-140-5p 介导的 FBN1 抑制促进骨肉瘤细胞的上皮-间充质转化、侵袭和转移。
Mol Oncol. 2020 Oct;14(10):2660-2677. doi: 10.1002/1878-0261.12711. Epub 2020 Aug 19.
10
LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.长链非编码 RNA FGD5-AS1 通过靶向 miR-142-5p 促进卵巢癌细胞的恶性表型。
Apoptosis. 2021 Jun;26(5-6):348-360. doi: 10.1007/s10495-021-01674-0. Epub 2021 May 11.